About the Event
Objectives:
- Describe the unmet need and residual risk of progression in CKD
- Review benefits of SGLT2 inhibitors in CKD
- Role of novel MRA treatment for CKD
- Understand potential role for emerging therapies for CKD Time
To learn more, click here for the Island Health medical staff calendar.